The universities usually only face the first stages of the cycle and the results do not mature, being difficult to transfer to the business world through the usual mechanisms. It is exactly at this point that we want to act.
The robustness and guarantee of success of this project is based on the application of the results and experience acquired during its predecessors: BIÓPOLIS (announcement PIC INTERREG IIIC), BIOPHARMAC (MAC/1/C104) and BIOTRANSFER (MAC/3/C224). BIOTRANSFER2 will serve as a tool to encourage the maturation of research, which will increase the capacity and effectiveness of the region's technological transfer and will favour bio-entrepreneurship and creation of technology-based spin-off companies, by contributing to the development of a favourable collaboration environment that allows such transfer of research results.
It will also serve to consolidate and improve the connectivity, communication and collaborations established between the different agents of the science, technology and business system, which will ultimately favour interregional collaboration. The participation and interaction of Universities, Science-Technology Parks and the business sector, encompasses the environment where a large part of the R&D activity is coordinated, working together to favor the current low social return, generating local economic activity and therefore increase employment.